Gene Symbol | Gene ID | Gene Info |
---|---|---|
Pparg
|
ENSMUSG00000000440.6 | peroxisome proliferator activated receptor gamma |
Rxrg
|
ENSMUSG00000015843.4 | retinoid X receptor gamma |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_115312557_115313010 | Pparg | 48168 | 0.115833 | -0.64 | 4.6e-08 | Click! |
chr6_115360907_115362191 | Pparg | 598 | 0.785311 | -0.52 | 1.9e-05 | Click! |
chr6_115343989_115344963 | Pparg | 16475 | 0.204877 | 0.34 | 7.6e-03 | Click! |
chr6_115441482_115441633 | Pparg | 1582 | 0.389913 | -0.23 | 8.4e-02 | Click! |
chr6_115360012_115360363 | Pparg | 764 | 0.705757 | -0.19 | 1.4e-01 | Click! |
chr1_167598414_167599474 | Rxrg | 464 | 0.876923 | -0.64 | 3.7e-08 | Click! |
chr1_167598017_167598407 | Rxrg | 172 | 0.968990 | -0.62 | 1.6e-07 | Click! |
chr1_167599773_167599924 | Rxrg | 1368 | 0.547218 | -0.44 | 4.4e-04 | Click! |
chr1_167608349_167608592 | Rxrg | 9839 | 0.265682 | -0.43 | 5.4e-04 | Click! |
chr1_167608175_167608346 | Rxrg | 9780 | 0.265893 | -0.42 | 7.6e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr8_94985246_94986199 | 16.41 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
154 |
0.93 |
chr5_114969022_114970855 | 16.34 |
Hnf1aos1 |
HNF1 homeobox A, opposite strand 1 |
18 |
0.91 |
chr8_120292266_120293650 | 14.22 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
64502 |
0.09 |
chr8_84703616_84705950 | 12.63 |
Nfix |
nuclear factor I/X |
2933 |
0.13 |
chr2_9882196_9886301 | 12.27 |
9230102O04Rik |
RIKEN cDNA 9230102O04 gene |
255 |
0.84 |
chr11_102360845_102363484 | 11.04 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
1540 |
0.24 |
chr8_23035959_23037041 | 10.57 |
Ank1 |
ankyrin 1, erythroid |
1269 |
0.45 |
chr8_122546551_122549259 | 10.56 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
3424 |
0.12 |
chr11_54025439_54026154 | 10.49 |
Slc22a4 |
solute carrier family 22 (organic cation transporter), member 4 |
2156 |
0.25 |
chr4_41096220_41096829 | 10.25 |
Aqp3 |
aquaporin 3 |
1659 |
0.24 |
chr15_76666348_76670076 | 10.14 |
Foxh1 |
forkhead box H1 |
1590 |
0.15 |
chr1_165769510_165770341 | 10.02 |
Creg1 |
cellular repressor of E1A-stimulated genes 1 |
449 |
0.66 |
chr10_75939108_75939976 | 10.01 |
Gm867 |
predicted gene 867 |
1069 |
0.25 |
chr11_96343236_96346574 | 9.78 |
Hoxb3 |
homeobox B3 |
1136 |
0.24 |
chr11_102364387_102365146 | 9.59 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
481 |
0.67 |
chr12_111442182_111444685 | 9.50 |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
771 |
0.51 |
chr11_103102696_103105788 | 9.48 |
Acbd4 |
acyl-Coenzyme A binding domain containing 4 |
463 |
0.7 |
chr6_52202371_52204739 | 9.47 |
Hoxa5 |
homeobox A5 |
1032 |
0.2 |
chr4_154024404_154026596 | 9.47 |
Smim1 |
small integral membrane protein 1 |
116 |
0.93 |
chr9_21963175_21963912 | 9.26 |
Epor |
erythropoietin receptor |
37 |
0.94 |
chr3_89386729_89388779 | 9.08 |
Zbtb7b |
zinc finger and BTB domain containing 7B |
83 |
0.91 |
chr5_64810297_64813272 | 9.08 |
Klf3 |
Kruppel-like factor 3 (basic) |
555 |
0.71 |
chr4_130173825_130175545 | 9.05 |
Tinagl1 |
tubulointerstitial nephritis antigen-like 1 |
6 |
0.97 |
chr7_127767459_127768302 | 8.98 |
Orai3 |
ORAI calcium release-activated calcium modulator 3 |
1935 |
0.14 |
chr15_103250315_103251530 | 8.82 |
Nfe2 |
nuclear factor, erythroid derived 2 |
543 |
0.62 |
chr8_88301330_88302008 | 8.75 |
Adcy7 |
adenylate cyclase 7 |
1290 |
0.46 |
chr12_86891509_86893562 | 8.64 |
Irf2bpl |
interferon regulatory factor 2 binding protein-like |
7737 |
0.19 |
chr11_98446534_98448432 | 8.61 |
Grb7 |
growth factor receptor bound protein 7 |
415 |
0.68 |
chr3_89136417_89137539 | 8.56 |
Pklr |
pyruvate kinase liver and red blood cell |
355 |
0.69 |
chr6_83068298_83071797 | 8.46 |
Tlx2 |
T cell leukemia, homeobox 2 |
178 |
0.81 |
chr6_87776091_87777171 | 8.43 |
Gm43904 |
predicted gene, 43904 |
488 |
0.55 |
chr7_143007094_143009025 | 8.43 |
Tspan32os |
tetraspanin 32, opposite strand |
26 |
0.96 |
chr9_22135450_22135674 | 8.36 |
Acp5 |
acid phosphatase 5, tartrate resistant |
129 |
0.9 |
chr10_67002257_67005140 | 8.24 |
Gm31763 |
predicted gene, 31763 |
1322 |
0.45 |
chr5_124049658_124050948 | 8.17 |
Gm43661 |
predicted gene 43661 |
2049 |
0.18 |
chr15_83169748_83171160 | 8.17 |
Cyb5r3 |
cytochrome b5 reductase 3 |
52 |
0.95 |
chr1_120269879_120270612 | 8.12 |
Steap3 |
STEAP family member 3 |
178 |
0.96 |
chr18_62176067_62177775 | 8.07 |
Adrb2 |
adrenergic receptor, beta 2 |
3038 |
0.24 |
chr4_46040988_46042013 | 8.06 |
Tmod1 |
tropomodulin 1 |
2291 |
0.3 |
chr14_33362281_33363618 | 8.06 |
Arhgap22 |
Rho GTPase activating protein 22 |
573 |
0.71 |
chr9_44285747_44286203 | 7.83 |
Abcg4 |
ATP binding cassette subfamily G member 4 |
1561 |
0.15 |
chr10_80856664_80858456 | 7.77 |
Sppl2b |
signal peptide peptidase like 2B |
439 |
0.61 |
chr1_130732649_130733832 | 7.74 |
AA986860 |
expressed sequence AA986860 |
1130 |
0.29 |
chr11_87756102_87757558 | 7.72 |
Mir142 |
microRNA 142 |
34 |
0.59 |
chr11_97511052_97512791 | 7.63 |
Gm11611 |
predicted gene 11611 |
9974 |
0.12 |
chr6_90324065_90325476 | 7.43 |
Chst13 |
carbohydrate sulfotransferase 13 |
415 |
0.73 |
chr11_32296600_32297646 | 7.37 |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
495 |
0.66 |
chr13_41019834_41020226 | 7.29 |
Tmem14c |
transmembrane protein 14C |
3738 |
0.15 |
chr7_4629257_4630354 | 7.27 |
Tmem86b |
transmembrane protein 86B |
382 |
0.66 |
chr7_139020697_139021233 | 7.10 |
Gm45613 |
predicted gene 45613 |
34 |
0.98 |
chr2_28907958_28910057 | 7.10 |
Barhl1 |
BarH like homeobox 1 |
3488 |
0.21 |
chr7_132776252_132776889 | 7.05 |
Fam53b |
family with sequence similarity 53, member B |
346 |
0.89 |
chr6_29694287_29695938 | 7.04 |
Tspan33 |
tetraspanin 33 |
878 |
0.58 |
chr8_84701273_84703379 | 7.00 |
Lyl1 |
lymphoblastomic leukemia 1 |
545 |
0.59 |
chr7_30493583_30494737 | 6.99 |
Prodh2 |
proline dehydrogenase (oxidase) 2 |
380 |
0.63 |
chr11_32283784_32284776 | 6.98 |
Hba-a1 |
hemoglobin alpha, adult chain 1 |
469 |
0.66 |
chr9_44340460_44342952 | 6.97 |
Hmbs |
hydroxymethylbilane synthase |
473 |
0.51 |
chr3_129216664_129219042 | 6.92 |
Pitx2 |
paired-like homeodomain transcription factor 2 |
3578 |
0.2 |
chr9_48648789_48650102 | 6.87 |
Nnmt |
nicotinamide N-methyltransferase |
44292 |
0.16 |
chrX_150547515_150548479 | 6.84 |
Alas2 |
aminolevulinic acid synthase 2, erythroid |
538 |
0.44 |
chr1_88407096_88408235 | 6.84 |
Spp2 |
secreted phosphoprotein 2 |
259 |
0.91 |
chr5_119685576_119687800 | 6.78 |
Tbx3os2 |
T-box 3, opposite strand 2 |
4530 |
0.17 |
chr10_59403301_59404650 | 6.71 |
Pla2g12b |
phospholipase A2, group XIIB |
315 |
0.88 |
chr11_117798237_117798922 | 6.69 |
6030468B19Rik |
RIKEN cDNA 6030468B19 gene |
919 |
0.33 |
chr7_133114831_133116529 | 6.65 |
Ctbp2 |
C-terminal binding protein 2 |
2981 |
0.2 |
chr11_4224803_4225158 | 6.63 |
Gm11956 |
predicted gene 11956 |
6285 |
0.1 |
chr11_98581976_98582749 | 6.51 |
Ormdl3 |
ORM1-like 3 (S. cerevisiae) |
5006 |
0.11 |
chr8_94986231_94987228 | 6.49 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
1161 |
0.36 |
chr19_10015065_10016667 | 6.49 |
Rab3il1 |
RAB3A interacting protein (rabin3)-like 1 |
822 |
0.48 |
chr6_72388069_72388633 | 6.44 |
Vamp8 |
vesicle-associated membrane protein 8 |
1560 |
0.22 |
chr5_147304305_147307985 | 6.43 |
Cdx2 |
caudal type homeobox 2 |
1125 |
0.33 |
chr8_120335264_120336251 | 6.33 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
107301 |
0.05 |
chr8_25542987_25545804 | 6.30 |
Gm16159 |
predicted gene 16159 |
9165 |
0.11 |
chr7_142662290_142664788 | 6.28 |
Igf2os |
insulin-like growth factor 2, opposite strand |
1599 |
0.21 |
chr8_122697547_122698708 | 6.24 |
Gm10612 |
predicted gene 10612 |
267 |
0.75 |
chr17_45592643_45594205 | 6.24 |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
210 |
0.86 |
chr11_117799058_117799291 | 6.12 |
6030468B19Rik |
RIKEN cDNA 6030468B19 gene |
1514 |
0.19 |
chrX_7965299_7965608 | 6.08 |
Gata1 |
GATA binding protein 1 |
1287 |
0.24 |
chr19_55941741_55942415 | 6.04 |
Tcf7l2 |
transcription factor 7 like 2, T cell specific, HMG box |
43769 |
0.16 |
chr14_48538424_48539155 | 5.96 |
4930572G02Rik |
RIKEN cDNA 4930572G02 gene |
430 |
0.76 |
chr5_120135981_120136359 | 5.94 |
Gm10390 |
predicted gene 10390 |
3091 |
0.26 |
chr8_122306253_122307213 | 5.92 |
Zfpm1 |
zinc finger protein, multitype 1 |
587 |
0.68 |
chr11_116076531_116078496 | 5.92 |
Unc13d |
unc-13 homolog D |
77 |
0.94 |
chr1_120267677_120268469 | 5.91 |
Steap3 |
STEAP family member 3 |
2350 |
0.36 |
chr18_62174392_62175675 | 5.90 |
Adrb2 |
adrenergic receptor, beta 2 |
4926 |
0.21 |
chr11_69364290_69367679 | 5.88 |
Chd3 |
chromodomain helicase DNA binding protein 3 |
1205 |
0.24 |
chr11_96347886_96350398 | 5.88 |
Hoxb3os |
homeobox B3 and homeobox B2, opposite strand |
1219 |
0.21 |
chr18_33461975_33464388 | 5.88 |
Nrep |
neuronal regeneration related protein |
254 |
0.86 |
chr2_127364227_127365175 | 5.88 |
Adra2b |
adrenergic receptor, alpha 2b |
1415 |
0.34 |
chr18_64483337_64484024 | 5.87 |
Fech |
ferrochelatase |
4169 |
0.19 |
chr5_137485098_137486372 | 5.86 |
Epo |
erythropoietin |
81 |
0.93 |
chr9_46228849_46229438 | 5.86 |
Apoa1 |
apolipoprotein A-I |
422 |
0.68 |
chr2_167588684_167589456 | 5.84 |
Gm11475 |
predicted gene 11475 |
2325 |
0.19 |
chr1_74949307_74952042 | 5.82 |
Ihh |
Indian hedgehog |
768 |
0.5 |
chr3_88364024_88365387 | 5.79 |
Paqr6 |
progestin and adipoQ receptor family member VI |
112 |
0.89 |
chr5_101979817_101980333 | 5.78 |
Wdfy3 |
WD repeat and FYVE domain containing 3 |
1483 |
0.43 |
chr9_103287942_103288250 | 5.78 |
1300017J02Rik |
RIKEN cDNA 1300017J02 gene |
128 |
0.96 |
chr4_118429529_118430133 | 5.77 |
Elovl1 |
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 1 |
130 |
0.92 |
chr5_139540206_139542054 | 5.74 |
Uncx |
UNC homeobox |
2364 |
0.26 |
chr4_134864478_134865098 | 5.72 |
Rhd |
Rh blood group, D antigen |
252 |
0.91 |
chr12_105034788_105035573 | 5.71 |
Glrx5 |
glutaredoxin 5 |
36 |
0.95 |
chr11_77892631_77894065 | 5.67 |
Pipox |
pipecolic acid oxidase |
748 |
0.58 |
chr6_41703661_41704308 | 5.67 |
Kel |
Kell blood group |
355 |
0.81 |
chr15_102150305_102151233 | 5.63 |
Soat2 |
sterol O-acyltransferase 2 |
243 |
0.86 |
chr5_37826544_37829286 | 5.63 |
Msx1 |
msh homeobox 1 |
3332 |
0.25 |
chr6_124662423_124664053 | 5.55 |
Lpcat3 |
lysophosphatidylcholine acyltransferase 3 |
23 |
0.95 |
chr8_69887012_69889642 | 5.54 |
Yjefn3 |
YjeF N-terminal domain containing 3 |
142 |
0.84 |
chr8_13204650_13205222 | 5.53 |
2810030D12Rik |
RIKEN cDNA 2810030D12 gene |
4116 |
0.12 |
chr15_103253562_103255772 | 5.53 |
Nfe2 |
nuclear factor, erythroid derived 2 |
605 |
0.57 |
chr7_44350602_44354420 | 5.52 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
1749 |
0.15 |
chr9_107589288_107589467 | 5.52 |
Ifrd2 |
interferon-related developmental regulator 2 |
1059 |
0.19 |
chr4_62515406_62516411 | 5.51 |
Alad |
aminolevulinate, delta-, dehydratase |
3973 |
0.13 |
chr2_121035039_121035972 | 5.51 |
Epb42 |
erythrocyte membrane protein band 4.2 |
1176 |
0.33 |
chr11_102145120_102148094 | 5.46 |
Nags |
N-acetylglutamate synthase |
241 |
0.58 |
chr9_43224450_43225086 | 5.45 |
Oaf |
out at first homolog |
324 |
0.86 |
chr7_18949615_18951696 | 5.43 |
Nova2 |
NOVA alternative splicing regulator 2 |
24767 |
0.07 |
chrX_85577312_85577893 | 5.41 |
Tab3 |
TGF-beta activated kinase 1/MAP3K7 binding protein 3 |
3452 |
0.27 |
chr5_35160468_35161280 | 5.39 |
Lrpap1 |
low density lipoprotein receptor-related protein associated protein 1 |
55108 |
0.11 |
chr14_54417149_54418129 | 5.39 |
Slc7a7 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 7 |
40 |
0.94 |
chr3_95172192_95174377 | 5.36 |
Sema6c |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6C |
2479 |
0.12 |
chrX_73909796_73911465 | 5.34 |
Arhgap4 |
Rho GTPase activating protein 4 |
599 |
0.57 |
chr11_95778990_95779141 | 5.33 |
Polr2k-ps |
polymerase (RNA) II (DNA directed) polypeptide K, pseudogene |
17574 |
0.11 |
chr19_24553917_24554867 | 5.31 |
Pip5k1b |
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
1397 |
0.38 |
chr7_103827140_103827838 | 5.31 |
Hbb-bs |
hemoglobin, beta adult s chain |
236 |
0.77 |
chr1_174173964_174174767 | 5.28 |
Spta1 |
spectrin alpha, erythrocytic 1 |
1589 |
0.22 |
chr11_60941500_60942391 | 5.27 |
Map2k3 |
mitogen-activated protein kinase kinase 3 |
65 |
0.96 |
chr19_44755099_44757716 | 5.25 |
Pax2 |
paired box 2 |
362 |
0.83 |
chr9_107489458_107490875 | 5.24 |
Cacna2d2 |
calcium channel, voltage-dependent, alpha 2/delta subunit 2 |
15438 |
0.08 |
chr9_98299474_98299912 | 5.22 |
Gm28530 |
predicted gene 28530 |
1957 |
0.33 |
chr17_35200817_35202291 | 5.22 |
Tnf |
tumor necrosis factor |
450 |
0.46 |
chr9_105520039_105521535 | 5.21 |
Atp2c1 |
ATPase, Ca++-sequestering |
360 |
0.86 |
chr7_103813135_103813893 | 5.21 |
Hbb-bt |
hemoglobin, beta adult t chain |
482 |
0.54 |
chr11_95344184_95344738 | 5.21 |
Fam117a |
family with sequence similarity 117, member A |
4499 |
0.14 |
chr7_98118384_98119588 | 5.20 |
Myo7a |
myosin VIIA |
506 |
0.78 |
chr5_139550965_139553757 | 5.20 |
Uncx |
UNC homeobox |
8463 |
0.18 |
chr16_91466275_91466861 | 5.19 |
Gm49626 |
predicted gene, 49626 |
1443 |
0.19 |
chr5_89456826_89457321 | 5.19 |
Gc |
vitamin D binding protein |
825 |
0.68 |
chr7_115844628_115845173 | 5.18 |
Sox6 |
SRY (sex determining region Y)-box 6 |
1205 |
0.62 |
chr2_91096772_91098746 | 5.17 |
Spi1 |
spleen focus forming virus (SFFV) proviral integration oncogene |
979 |
0.4 |
chr16_20701494_20702997 | 5.16 |
Fam131a |
family with sequence similarity 131, member A |
6070 |
0.08 |
chr5_123131617_123134965 | 5.16 |
Rhof |
ras homolog family member F (in filopodia) |
599 |
0.36 |
chr11_97442581_97443059 | 5.15 |
Arhgap23 |
Rho GTPase activating protein 23 |
6535 |
0.17 |
chr2_84800179_84800339 | 5.14 |
Ube2l6 |
ubiquitin-conjugating enzyme E2L 6 |
1425 |
0.25 |
chr5_31251110_31252754 | 5.14 |
Krtcap3 |
keratinocyte associated protein 3 |
5 |
0.93 |
chr8_57320946_57324000 | 5.13 |
Hand2os1 |
Hand2, opposite strand 1 |
1245 |
0.3 |
chr11_96282910_96285155 | 5.11 |
Hoxb8 |
homeobox B8 |
1307 |
0.19 |
chr5_140607303_140609715 | 5.10 |
Lfng |
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
1189 |
0.34 |
chr4_46854379_46855929 | 5.10 |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
4748 |
0.3 |
chr17_36869615_36870619 | 5.10 |
Trim10 |
tripartite motif-containing 10 |
543 |
0.55 |
chr14_69496105_69496294 | 5.09 |
Gm37094 |
predicted gene, 37094 |
4191 |
0.12 |
chr14_69277855_69278048 | 5.08 |
Gm20236 |
predicted gene, 20236 |
4189 |
0.11 |
chr2_155988856_155989174 | 5.08 |
Cep250 |
centrosomal protein 250 |
3100 |
0.14 |
chr13_21913780_21914888 | 5.07 |
Gm44456 |
predicted gene, 44456 |
10682 |
0.06 |
chr12_95693703_95697493 | 5.06 |
Flrt2 |
fibronectin leucine rich transmembrane protein 2 |
241 |
0.92 |
chr18_11051784_11053949 | 5.04 |
Gata6 |
GATA binding protein 6 |
178 |
0.66 |
chr11_75450553_75451558 | 5.03 |
Wdr81 |
WD repeat domain 81 |
28 |
0.94 |
chr18_20666097_20666725 | 5.01 |
Ttr |
transthyretin |
1131 |
0.34 |
chr4_132065737_132066558 | 4.98 |
Epb41 |
erythrocyte membrane protein band 4.1 |
5950 |
0.12 |
chr9_21961394_21962913 | 4.97 |
Epor |
erythropoietin receptor |
411 |
0.68 |
chr8_89041062_89042862 | 4.97 |
Sall1 |
spalt like transcription factor 1 |
2200 |
0.35 |
chr11_79071094_79071622 | 4.96 |
Ksr1 |
kinase suppressor of ras 1 |
3128 |
0.28 |
chr19_40812757_40814183 | 4.94 |
Ccnj |
cyclin J |
17809 |
0.16 |
chr7_25217464_25218200 | 4.94 |
Mir7048 |
microRNA 7048 |
107 |
0.9 |
chr2_163549842_163550031 | 4.91 |
Hnf4a |
hepatic nuclear factor 4, alpha |
147 |
0.94 |
chr18_64331856_64333830 | 4.90 |
St8sia3os |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3, opposite strand |
863 |
0.56 |
chr15_97379421_97380753 | 4.90 |
Pced1b |
PC-esterase domain containing 1B |
18870 |
0.24 |
chrX_7966827_7967869 | 4.86 |
Gata1 |
GATA binding protein 1 |
562 |
0.55 |
chr8_84836764_84838739 | 4.86 |
Rad23a |
RAD23 homolog A, nucleotide excision repair protein |
296 |
0.75 |
chr10_75937829_75938478 | 4.81 |
Chchd10 |
coiled-coil-helix-coiled-coil-helix domain containing 10 |
933 |
0.28 |
chr7_45574320_45575183 | 4.80 |
Bcat2 |
branched chain aminotransferase 2, mitochondrial |
349 |
0.43 |
chr18_21152486_21153141 | 4.79 |
Gm6378 |
predicted pseudogene 6378 |
75704 |
0.09 |
chr5_115948395_115949019 | 4.79 |
Cit |
citron |
2383 |
0.26 |
chr6_122393147_122393385 | 4.78 |
1700063H04Rik |
RIKEN cDNA 1700063H04 gene |
1887 |
0.24 |
chr4_152447653_152448768 | 4.77 |
Kcnab2 |
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
531 |
0.76 |
chr16_32508454_32509173 | 4.76 |
Zdhhc19 |
zinc finger, DHHC domain containing 19 |
9202 |
0.13 |
chr10_70127197_70127431 | 4.75 |
Ccdc6 |
coiled-coil domain containing 6 |
30193 |
0.2 |
chr7_90045322_90045732 | 4.75 |
Gm44861 |
predicted gene 44861 |
2830 |
0.19 |
chr9_114562610_114564528 | 4.75 |
Trim71 |
tripartite motif-containing 71 |
800 |
0.6 |
chr16_38294375_38294815 | 4.75 |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
229 |
0.9 |
chr9_107975554_107976970 | 4.74 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
46 |
0.91 |
chr9_99874679_99877472 | 4.74 |
Sox14 |
SRY (sex determining region Y)-box 14 |
95 |
0.97 |
chrX_8273039_8273807 | 4.74 |
Slc38a5 |
solute carrier family 38, member 5 |
1781 |
0.27 |
chr8_123978308_123979538 | 4.73 |
Abcb10 |
ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
4199 |
0.12 |
chr12_76706065_76706252 | 4.73 |
Sptb |
spectrin beta, erythrocytic |
3865 |
0.24 |
chr11_102308792_102311562 | 4.72 |
Ubtf |
upstream binding transcription factor, RNA polymerase I |
269 |
0.84 |
chr13_58522751_58523890 | 4.72 |
Gm3131 |
predicted gene 3131 |
22708 |
0.16 |
chr13_3891572_3893506 | 4.69 |
Net1 |
neuroepithelial cell transforming gene 1 |
894 |
0.46 |
chr7_115845255_115845445 | 4.69 |
Sox6 |
SRY (sex determining region Y)-box 6 |
755 |
0.78 |
chr14_63268302_63270010 | 4.68 |
Gata4 |
GATA binding protein 4 |
1968 |
0.31 |
chr19_7294483_7295524 | 4.67 |
Mark2 |
MAP/microtubule affinity regulating kinase 2 |
444 |
0.7 |
chr7_100492685_100494805 | 4.66 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
50 |
0.95 |
chr18_20640865_20641610 | 4.66 |
Gm16090 |
predicted gene 16090 |
24023 |
0.15 |
chr1_172501767_172503923 | 4.65 |
Tagln2 |
transgelin 2 |
1593 |
0.22 |
chr9_15301310_15301945 | 4.65 |
4931406C07Rik |
RIKEN cDNA 4931406C07 gene |
71 |
0.89 |
chr12_32104342_32104636 | 4.65 |
5430401H09Rik |
RIKEN cDNA 5430401H09 gene |
19213 |
0.16 |
chr15_38077521_38078812 | 4.64 |
Ubr5 |
ubiquitin protein ligase E3 component n-recognin 5 |
259 |
0.83 |
chr2_25577192_25580600 | 4.64 |
Ajm1 |
apical junction component 1 |
1001 |
0.25 |
chr7_4751858_4753020 | 4.64 |
Cox6b2 |
cytochrome c oxidase subunit 6B2 |
89 |
0.92 |
chr9_21183634_21184964 | 4.62 |
Pde4a |
phosphodiesterase 4A, cAMP specific |
196 |
0.89 |
chr10_80332301_80332841 | 4.62 |
Reep6 |
receptor accessory protein 6 |
2369 |
0.1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.0 | 14.9 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
3.9 | 15.5 | GO:1900212 | mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) |
3.8 | 11.5 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
3.5 | 14.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
3.2 | 12.9 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
3.2 | 6.4 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
3.0 | 24.4 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
3.0 | 9.1 | GO:0002432 | granuloma formation(GO:0002432) |
2.8 | 8.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
2.5 | 5.1 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
2.5 | 7.5 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
2.4 | 7.2 | GO:0006562 | proline catabolic process(GO:0006562) |
2.4 | 58.9 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
2.3 | 7.0 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
2.3 | 6.9 | GO:2000562 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
2.3 | 9.0 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
2.2 | 9.0 | GO:0097460 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) |
2.2 | 6.6 | GO:0042908 | xenobiotic transport(GO:0042908) |
2.2 | 10.9 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
2.2 | 6.5 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
2.1 | 8.3 | GO:0015793 | glycerol transport(GO:0015793) |
2.0 | 2.0 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
2.0 | 8.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
2.0 | 8.1 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
2.0 | 14.1 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
2.0 | 5.9 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
1.9 | 5.8 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.9 | 9.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.9 | 7.6 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.9 | 5.7 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.9 | 3.7 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
1.8 | 1.8 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
1.8 | 7.2 | GO:0021569 | rhombomere 3 development(GO:0021569) |
1.8 | 5.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.8 | 7.2 | GO:0006742 | NADP catabolic process(GO:0006742) |
1.8 | 3.5 | GO:0001555 | oocyte growth(GO:0001555) |
1.8 | 5.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.7 | 14.0 | GO:0032782 | bile acid secretion(GO:0032782) |
1.7 | 10.5 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
1.7 | 5.1 | GO:0036394 | amylase secretion(GO:0036394) |
1.7 | 5.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.7 | 5.1 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
1.7 | 38.6 | GO:0048821 | erythrocyte development(GO:0048821) |
1.7 | 3.3 | GO:0046104 | thymidine metabolic process(GO:0046104) |
1.7 | 6.6 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
1.6 | 4.9 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
1.6 | 9.9 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
1.6 | 4.8 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.6 | 3.2 | GO:0046618 | drug export(GO:0046618) |
1.6 | 4.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
1.6 | 1.6 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
1.6 | 4.7 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
1.6 | 3.1 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.6 | 14.0 | GO:0070269 | pyroptosis(GO:0070269) |
1.5 | 3.1 | GO:0046084 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
1.5 | 4.6 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
1.5 | 4.6 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
1.5 | 1.5 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.5 | 6.0 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
1.5 | 6.0 | GO:0032264 | IMP salvage(GO:0032264) |
1.5 | 1.5 | GO:0035754 | B cell chemotaxis(GO:0035754) |
1.5 | 5.9 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
1.5 | 4.4 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
1.4 | 2.9 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
1.4 | 2.9 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
1.4 | 7.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
1.4 | 2.9 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
1.4 | 4.3 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
1.4 | 16.9 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
1.4 | 4.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.4 | 1.4 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.4 | 4.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
1.3 | 4.0 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
1.3 | 12.0 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.3 | 8.0 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
1.3 | 4.0 | GO:0009139 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
1.3 | 2.6 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
1.3 | 3.9 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.3 | 2.6 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
1.3 | 5.2 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
1.3 | 5.2 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
1.3 | 3.9 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.3 | 6.4 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.3 | 3.9 | GO:0000087 | mitotic M phase(GO:0000087) |
1.3 | 3.9 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
1.3 | 2.5 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
1.3 | 1.3 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
1.3 | 3.8 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.3 | 5.0 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
1.3 | 6.3 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
1.3 | 3.8 | GO:0002930 | trabecular meshwork development(GO:0002930) |
1.3 | 6.3 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
1.3 | 2.5 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
1.2 | 3.7 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
1.2 | 2.5 | GO:0048793 | pronephros development(GO:0048793) |
1.2 | 1.2 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
1.2 | 3.7 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
1.2 | 3.7 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
1.2 | 4.9 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
1.2 | 4.9 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.2 | 1.2 | GO:1904672 | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) regulation of somatic stem cell population maintenance(GO:1904672) negative regulation of somatic stem cell population maintenance(GO:1904673) |
1.2 | 6.0 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
1.2 | 3.6 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.2 | 1.2 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
1.2 | 1.2 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
1.2 | 1.2 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
1.2 | 3.5 | GO:0070268 | cornification(GO:0070268) |
1.2 | 18.6 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
1.2 | 2.3 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
1.1 | 1.1 | GO:0021570 | rhombomere 4 development(GO:0021570) |
1.1 | 4.6 | GO:0023021 | termination of signal transduction(GO:0023021) |
1.1 | 2.3 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
1.1 | 3.3 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
1.1 | 3.3 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
1.1 | 5.5 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
1.1 | 3.3 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.1 | 6.6 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
1.1 | 5.5 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
1.1 | 8.7 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
1.1 | 3.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.1 | 4.3 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
1.1 | 8.5 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
1.1 | 2.1 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
1.0 | 1.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
1.0 | 3.1 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
1.0 | 3.1 | GO:0008228 | opsonization(GO:0008228) |
1.0 | 3.1 | GO:0035973 | aggrephagy(GO:0035973) |
1.0 | 3.1 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.0 | 6.2 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
1.0 | 2.1 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
1.0 | 3.0 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.0 | 2.0 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
1.0 | 3.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.0 | 3.0 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
1.0 | 3.0 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
1.0 | 1.0 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
1.0 | 3.0 | GO:0035483 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
1.0 | 2.0 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
1.0 | 2.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
1.0 | 3.0 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
1.0 | 3.9 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.0 | 2.0 | GO:0060056 | mammary gland involution(GO:0060056) |
1.0 | 4.9 | GO:0015879 | carnitine transport(GO:0015879) |
1.0 | 6.9 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
1.0 | 2.9 | GO:0061010 | gall bladder development(GO:0061010) |
1.0 | 3.9 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
1.0 | 1.0 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
1.0 | 2.9 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
1.0 | 4.8 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
1.0 | 4.8 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
1.0 | 1.0 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
1.0 | 3.9 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
1.0 | 2.9 | GO:0070488 | neutrophil aggregation(GO:0070488) |
1.0 | 3.9 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.9 | 1.9 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.9 | 0.9 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.9 | 0.9 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.9 | 5.6 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.9 | 1.9 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.9 | 1.9 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.9 | 1.9 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.9 | 14.8 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.9 | 0.9 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.9 | 8.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.9 | 2.8 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.9 | 6.4 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.9 | 0.9 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) positive regulation of deoxyribonuclease activity(GO:0032077) |
0.9 | 4.6 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.9 | 2.7 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.9 | 2.7 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.9 | 0.9 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.9 | 6.4 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.9 | 2.7 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.9 | 2.7 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.9 | 0.9 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.9 | 0.9 | GO:0021546 | rhombomere development(GO:0021546) |
0.9 | 2.7 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.9 | 0.9 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.9 | 6.2 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.9 | 1.8 | GO:0060066 | oviduct development(GO:0060066) |
0.9 | 3.5 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.9 | 2.6 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.9 | 1.7 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.9 | 7.7 | GO:0034063 | stress granule assembly(GO:0034063) |
0.9 | 0.9 | GO:0097459 | iron ion import into cell(GO:0097459) |
0.9 | 0.9 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
0.9 | 6.0 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.9 | 10.2 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.8 | 7.6 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.8 | 7.5 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.8 | 1.7 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.8 | 1.7 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.8 | 1.7 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.8 | 3.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.8 | 1.6 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.8 | 3.3 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.8 | 0.8 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.8 | 2.4 | GO:0019401 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
0.8 | 3.3 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.8 | 3.2 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.8 | 1.6 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.8 | 4.8 | GO:0051639 | actin filament network formation(GO:0051639) |
0.8 | 1.6 | GO:0015677 | copper ion import(GO:0015677) |
0.8 | 0.8 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.8 | 0.8 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.8 | 14.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.8 | 1.6 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
0.8 | 2.4 | GO:0019532 | oxalate transport(GO:0019532) |
0.8 | 3.2 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.8 | 3.2 | GO:0044838 | cell quiescence(GO:0044838) |
0.8 | 1.6 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.8 | 1.6 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.8 | 1.6 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.8 | 1.6 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.8 | 11.0 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.8 | 3.1 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.8 | 3.9 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.8 | 2.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.8 | 1.5 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.8 | 0.8 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.8 | 2.3 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.8 | 7.0 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.8 | 1.5 | GO:0030421 | defecation(GO:0030421) |
0.8 | 6.2 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.8 | 1.5 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.8 | 8.5 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.8 | 2.3 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.8 | 0.8 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.8 | 3.8 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.8 | 3.8 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.8 | 3.1 | GO:0001802 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.8 | 1.5 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.8 | 2.3 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.8 | 1.5 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.8 | 3.0 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.8 | 1.5 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.8 | 2.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.8 | 2.3 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.7 | 2.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.7 | 2.2 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.7 | 2.2 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.7 | 1.5 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.7 | 2.2 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.7 | 1.4 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.7 | 0.7 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.7 | 4.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.7 | 3.6 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.7 | 2.2 | GO:0097286 | iron ion import(GO:0097286) |
0.7 | 2.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.7 | 2.1 | GO:0042117 | monocyte activation(GO:0042117) |
0.7 | 2.9 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.7 | 0.7 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.7 | 2.1 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.7 | 1.4 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.7 | 2.1 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.7 | 2.1 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.7 | 2.8 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.7 | 1.4 | GO:1901838 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.7 | 0.7 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.7 | 2.1 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.7 | 1.4 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.7 | 0.7 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.7 | 2.1 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.7 | 1.4 | GO:0048371 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.7 | 2.7 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.7 | 6.8 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.7 | 6.1 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.7 | 2.0 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.7 | 4.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.7 | 4.7 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.7 | 2.0 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.7 | 2.0 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.7 | 2.0 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.7 | 0.7 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.7 | 0.7 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.7 | 3.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.7 | 1.3 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.7 | 0.7 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.7 | 2.6 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.7 | 5.9 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.6 | 1.3 | GO:1902075 | cellular response to salt(GO:1902075) |
0.6 | 1.3 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.6 | 1.9 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.6 | 1.3 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.6 | 1.9 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.6 | 3.8 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.6 | 1.9 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.6 | 6.3 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.6 | 3.1 | GO:0018101 | protein citrullination(GO:0018101) |
0.6 | 1.9 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.6 | 4.4 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.6 | 1.9 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.6 | 1.3 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.6 | 2.5 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.6 | 1.9 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.6 | 2.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.6 | 5.0 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.6 | 3.1 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.6 | 1.9 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.6 | 1.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.6 | 3.7 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.6 | 1.2 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.6 | 2.5 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.6 | 1.2 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.6 | 4.3 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.6 | 3.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.6 | 5.5 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.6 | 4.9 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.6 | 4.3 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.6 | 2.4 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.6 | 1.2 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.6 | 3.0 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.6 | 1.2 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.6 | 1.8 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.6 | 2.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.6 | 1.2 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.6 | 0.6 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.6 | 4.8 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.6 | 4.7 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.6 | 2.9 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.6 | 1.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.6 | 1.2 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.6 | 2.3 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.6 | 0.6 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.6 | 0.6 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.6 | 2.9 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.6 | 2.3 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.6 | 2.3 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.6 | 2.3 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.6 | 1.7 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.6 | 2.3 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.6 | 9.1 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.6 | 1.7 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.6 | 1.1 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.6 | 1.1 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.6 | 2.8 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
0.6 | 7.9 | GO:0015858 | nucleoside transport(GO:0015858) |
0.6 | 1.1 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.6 | 1.1 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.6 | 2.8 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.6 | 1.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.6 | 1.7 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.6 | 2.2 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.6 | 2.8 | GO:0018904 | ether metabolic process(GO:0018904) |
0.6 | 4.4 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.6 | 3.3 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.6 | 3.9 | GO:2000726 | negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.5 | 1.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.5 | 0.5 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.5 | 0.5 | GO:0015886 | heme transport(GO:0015886) |
0.5 | 1.6 | GO:0018343 | protein farnesylation(GO:0018343) |
0.5 | 2.2 | GO:0009597 | detection of virus(GO:0009597) |
0.5 | 2.7 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.5 | 0.5 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.5 | 1.6 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.5 | 0.5 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.5 | 2.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.5 | 3.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.5 | 1.1 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.5 | 2.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.5 | 1.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.5 | 5.9 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.5 | 4.3 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.5 | 2.7 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.5 | 1.1 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.5 | 0.5 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.5 | 6.9 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.5 | 4.2 | GO:0046688 | response to copper ion(GO:0046688) |
0.5 | 0.5 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.5 | 2.6 | GO:0036233 | glycine import(GO:0036233) |
0.5 | 3.7 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.5 | 8.4 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.5 | 1.6 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.5 | 1.6 | GO:0061511 | centriole elongation(GO:0061511) |
0.5 | 0.5 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.5 | 4.2 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.5 | 2.6 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.5 | 1.6 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.5 | 3.1 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.5 | 0.5 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.5 | 6.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.5 | 1.0 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.5 | 0.5 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.5 | 1.0 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.5 | 2.6 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.5 | 3.1 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.5 | 2.6 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.5 | 1.5 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.5 | 1.5 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.5 | 0.5 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.5 | 1.5 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.5 | 4.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.5 | 6.6 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.5 | 1.5 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.5 | 1.0 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.5 | 1.0 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.5 | 1.5 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.5 | 3.0 | GO:0051451 | myoblast migration(GO:0051451) |
0.5 | 1.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.5 | 1.5 | GO:0032439 | endosome localization(GO:0032439) |
0.5 | 1.0 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.5 | 2.5 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.5 | 1.0 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.5 | 1.5 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.5 | 3.5 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.5 | 2.0 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.5 | 1.0 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.5 | 5.4 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.5 | 1.5 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.5 | 1.5 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.5 | 1.5 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.5 | 1.0 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.5 | 1.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.5 | 2.4 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.5 | 2.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.5 | 1.9 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.5 | 0.5 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.5 | 1.9 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.5 | 0.5 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.5 | 2.4 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.5 | 4.3 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.5 | 1.4 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.5 | 2.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.5 | 1.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.5 | 2.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.5 | 1.4 | GO:0006116 | NADH oxidation(GO:0006116) |
0.5 | 0.5 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.5 | 1.4 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.5 | 1.9 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.5 | 0.5 | GO:0003160 | endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
0.5 | 3.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.5 | 3.7 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.5 | 0.5 | GO:0002190 | cap-independent translational initiation(GO:0002190) |
0.5 | 0.9 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.5 | 1.4 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.5 | 1.4 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.5 | 2.3 | GO:0002295 | T-helper cell lineage commitment(GO:0002295) T-helper 17 cell lineage commitment(GO:0072540) |
0.5 | 1.4 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.5 | 2.3 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
0.5 | 2.8 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.5 | 0.9 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.5 | 1.4 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.5 | 0.5 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.5 | 3.7 | GO:0097006 | regulation of plasma lipoprotein particle levels(GO:0097006) |
0.5 | 0.9 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.5 | 0.5 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.5 | 0.5 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.5 | 0.5 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.5 | 1.8 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.5 | 2.3 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.5 | 0.9 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.5 | 0.9 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.5 | 2.3 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.5 | 1.4 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.5 | 0.5 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.5 | 2.3 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.5 | 2.7 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.5 | 0.5 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.5 | 0.9 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.5 | 3.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.5 | 1.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.5 | 2.7 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.5 | 0.9 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.5 | 1.8 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.4 | 3.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.4 | 4.5 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.4 | 0.9 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.4 | 0.4 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.4 | 0.4 | GO:2000974 | negative regulation of pro-B cell differentiation(GO:2000974) regulation of forebrain neuron differentiation(GO:2000977) negative regulation of forebrain neuron differentiation(GO:2000978) |
0.4 | 0.4 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.4 | 1.3 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.4 | 0.9 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.4 | 1.8 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.4 | 0.9 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.4 | 4.4 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.4 | 0.9 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.4 | 1.7 | GO:0031033 | myosin filament organization(GO:0031033) |
0.4 | 3.0 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.4 | 0.9 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.4 | 1.7 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.4 | 6.5 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.4 | 2.2 | GO:1904970 | brush border assembly(GO:1904970) |
0.4 | 2.6 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.4 | 5.2 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.4 | 0.9 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.4 | 2.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.4 | 1.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.4 | 0.9 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.4 | 5.6 | GO:0044818 | mitotic G2 DNA damage checkpoint(GO:0007095) mitotic G2/M transition checkpoint(GO:0044818) |
0.4 | 0.4 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.4 | 0.4 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.4 | 0.9 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
0.4 | 4.2 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.4 | 1.3 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.4 | 2.5 | GO:0042168 | heme metabolic process(GO:0042168) |
0.4 | 0.8 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.4 | 3.4 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.4 | 0.4 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.4 | 5.1 | GO:0051601 | exocyst localization(GO:0051601) |
0.4 | 6.7 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.4 | 1.7 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.4 | 0.8 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.4 | 1.7 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.4 | 0.4 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
0.4 | 3.8 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.4 | 2.1 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.4 | 0.4 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.4 | 2.9 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.4 | 0.8 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.4 | 0.4 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.4 | 5.8 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.4 | 0.4 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.4 | 4.5 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.4 | 0.4 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.4 | 0.8 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.4 | 1.6 | GO:0051031 | tRNA transport(GO:0051031) |
0.4 | 1.6 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.4 | 2.0 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.4 | 11.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.4 | 0.4 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.4 | 0.8 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.4 | 0.8 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.4 | 1.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.4 | 0.8 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.4 | 0.4 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.4 | 2.0 | GO:1901341 | positive regulation of store-operated calcium channel activity(GO:1901341) |
0.4 | 1.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.4 | 4.4 | GO:0006465 | signal peptide processing(GO:0006465) |
0.4 | 2.4 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.4 | 0.4 | GO:0000050 | urea cycle(GO:0000050) |
0.4 | 3.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.4 | 0.8 | GO:0051917 | regulation of fibrinolysis(GO:0051917) positive regulation of fibrinolysis(GO:0051919) |
0.4 | 2.3 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.4 | 0.4 | GO:0043366 | beta selection(GO:0043366) |
0.4 | 1.6 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.4 | 1.6 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.4 | 5.4 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.4 | 0.4 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.4 | 2.3 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.4 | 0.4 | GO:0048382 | mesendoderm development(GO:0048382) |
0.4 | 1.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.4 | 1.1 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.4 | 0.4 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.4 | 1.5 | GO:0034204 | lipid translocation(GO:0034204) |
0.4 | 0.4 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.4 | 0.8 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.4 | 0.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.4 | 1.9 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.4 | 1.9 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.4 | 1.1 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.4 | 1.5 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.4 | 1.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.4 | 1.1 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.4 | 3.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.4 | 7.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.4 | 0.7 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.4 | 0.4 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.4 | 2.6 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.4 | 1.1 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.4 | 0.7 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.4 | 1.1 | GO:0003383 | apical constriction(GO:0003383) |
0.4 | 0.4 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.4 | 1.5 | GO:0009642 | response to light intensity(GO:0009642) |
0.4 | 0.7 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.4 | 1.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.4 | 1.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.4 | 3.3 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.4 | 2.2 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.4 | 1.1 | GO:0031577 | spindle checkpoint(GO:0031577) |
0.4 | 1.1 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.4 | 0.7 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.4 | 0.4 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.4 | 1.1 | GO:1904666 | regulation of ubiquitin protein ligase activity(GO:1904666) positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.4 | 0.7 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.4 | 0.7 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.4 | 1.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.4 | 0.4 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
0.4 | 0.4 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.4 | 6.0 | GO:0030488 | tRNA methylation(GO:0030488) |
0.4 | 1.1 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.4 | 1.4 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.3 | 2.8 | GO:0090224 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.3 | 1.0 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.3 | 1.7 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.3 | 1.0 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.3 | 2.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.3 | 0.3 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.3 | 2.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.3 | 1.7 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.3 | 2.4 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.3 | 1.0 | GO:0002254 | kinin cascade(GO:0002254) |
0.3 | 2.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.3 | 3.1 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.3 | 0.3 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.3 | 1.7 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.3 | 1.4 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.3 | 1.0 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.3 | 0.7 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.3 | 0.3 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.3 | 1.4 | GO:0042730 | fibrinolysis(GO:0042730) |
0.3 | 1.7 | GO:0060613 | fat pad development(GO:0060613) |
0.3 | 0.3 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.3 | 4.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.3 | 0.7 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.3 | 0.3 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.3 | 1.7 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.3 | 0.7 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.3 | 2.0 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.3 | 2.7 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.3 | 1.3 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.3 | 1.0 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.3 | 0.7 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.3 | 1.3 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.3 | 0.7 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.3 | 1.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.3 | 0.7 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.3 | 0.3 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.3 | 0.3 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.3 | 0.7 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.3 | 2.3 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.3 | 0.3 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.3 | 9.8 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.3 | 1.3 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.3 | 3.9 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.3 | 1.0 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.3 | 0.3 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.3 | 0.3 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.3 | 1.0 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.3 | 0.3 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.3 | 0.6 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.3 | 0.6 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.3 | 1.0 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.3 | 0.3 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
0.3 | 0.3 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.3 | 3.5 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
0.3 | 0.6 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.3 | 1.0 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 2.5 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.3 | 1.3 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.3 | 1.3 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.3 | 1.3 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.3 | 0.9 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.3 | 0.9 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.3 | 0.3 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.3 | 1.3 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.3 | 0.9 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.3 | 0.9 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.3 | 1.6 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.3 | 0.3 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.3 | 0.9 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.3 | 1.2 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.3 | 1.2 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.3 | 0.6 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.3 | 3.1 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.3 | 1.2 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.3 | 0.6 | GO:0006415 | translational termination(GO:0006415) |
0.3 | 0.3 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.3 | 0.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.3 | 13.0 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.3 | 0.3 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.3 | 1.5 | GO:0046415 | urate metabolic process(GO:0046415) |
0.3 | 0.3 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.3 | 1.5 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.3 | 0.9 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
0.3 | 0.6 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.3 | 0.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.3 | 2.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.3 | 0.6 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.3 | 2.7 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.3 | 0.9 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.3 | 1.2 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.3 | 0.9 | GO:0001842 | neural fold formation(GO:0001842) |
0.3 | 0.3 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.3 | 1.2 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.3 | 6.5 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.3 | 0.3 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.3 | 6.8 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.3 | 2.9 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.3 | 0.6 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.3 | 0.9 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.3 | 0.6 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.3 | 9.6 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.3 | 2.6 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.3 | 2.3 | GO:0051382 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
0.3 | 0.6 | GO:0090009 | primitive streak formation(GO:0090009) |
0.3 | 2.9 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.3 | 2.9 | GO:0034340 | response to type I interferon(GO:0034340) |
0.3 | 1.2 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.3 | 0.9 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.3 | 0.6 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.3 | 0.3 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.3 | 0.3 | GO:0003166 | bundle of His development(GO:0003166) |
0.3 | 3.7 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.3 | 0.3 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.3 | 0.3 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.3 | 2.5 | GO:0006968 | cellular defense response(GO:0006968) |
0.3 | 0.3 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.3 | 0.3 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.3 | 0.6 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.3 | 0.3 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.3 | 0.6 | GO:0033762 | response to glucagon(GO:0033762) |
0.3 | 7.6 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.3 | 1.4 | GO:0034695 | response to prostaglandin E(GO:0034695) cellular response to prostaglandin E stimulus(GO:0071380) |
0.3 | 0.6 | GO:0019086 | late viral transcription(GO:0019086) |
0.3 | 0.3 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.3 | 2.0 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.3 | 0.3 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.3 | 0.3 | GO:0060526 | prostate glandular acinus development(GO:0060525) prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.3 | 1.7 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.3 | 0.6 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.3 | 2.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.3 | 0.6 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.3 | 0.5 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.3 | 1.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.3 | 0.8 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.3 | 0.5 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.3 | 0.3 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.3 | 0.3 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.3 | 1.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.3 | 1.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.3 | 4.1 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.3 | 1.9 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.3 | 0.5 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.3 | 1.6 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.3 | 0.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.3 | 1.1 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.3 | 0.8 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.3 | 3.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.3 | 0.5 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.3 | 1.1 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.3 | 0.8 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.3 | 0.5 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.3 | 2.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.3 | 0.8 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.3 | 1.9 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.3 | 1.3 | GO:0009310 | amine catabolic process(GO:0009310) |
0.3 | 0.3 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.3 | 1.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.3 | 1.3 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.3 | 0.5 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.3 | 0.3 | GO:0050904 | diapedesis(GO:0050904) |
0.3 | 0.8 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.3 | 1.9 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.3 | 0.5 | GO:0002215 | defense response to nematode(GO:0002215) |
0.3 | 2.1 | GO:0061515 | myeloid cell development(GO:0061515) |
0.3 | 0.5 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.3 | 0.3 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.3 | 1.6 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.3 | 1.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.3 | 1.3 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.3 | 0.5 | GO:1990144 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.3 | 5.8 | GO:0006953 | acute-phase response(GO:0006953) |
0.3 | 2.3 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.3 | 2.8 | GO:0031167 | rRNA methylation(GO:0031167) |
0.3 | 1.3 | GO:0015825 | L-serine transport(GO:0015825) |
0.3 | 0.8 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.3 | 3.1 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.3 | 0.3 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.3 | 1.0 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.3 | 1.0 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.3 | 0.3 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.3 | 1.5 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.3 | 0.5 | GO:0009162 | nucleoside monophosphate catabolic process(GO:0009125) deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.3 | 0.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.3 | 0.3 | GO:0042762 | regulation of sulfur metabolic process(GO:0042762) |
0.3 | 0.3 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.3 | 0.5 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.3 | 0.3 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.3 | 0.3 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.3 | 0.3 | GO:0032329 | serine transport(GO:0032329) |
0.3 | 3.5 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.3 | 3.0 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.3 | 0.8 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.2 | 1.2 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.2 | 0.2 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.2 | 0.5 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.2 | 1.2 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.2 | 0.5 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 0.5 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.2 | 1.0 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.2 | 1.2 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 1.5 | GO:0050779 | RNA destabilization(GO:0050779) |
0.2 | 0.5 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.2 | 4.9 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.2 | 0.2 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.2 | 1.2 | GO:0035878 | nail development(GO:0035878) |
0.2 | 0.5 | GO:0033058 | directional locomotion(GO:0033058) |
0.2 | 0.5 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 1.0 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.2 | 0.7 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.2 | 0.5 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.2 | 0.7 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 0.5 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.2 | 2.9 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 0.2 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.2 | 3.6 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 0.5 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.2 | 0.2 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.2 | 1.9 | GO:0060143 | positive regulation of syncytium formation by plasma membrane fusion(GO:0060143) |
0.2 | 0.9 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.2 | 0.2 | GO:0002830 | positive regulation of type 2 immune response(GO:0002830) |
0.2 | 0.2 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.2 | 0.9 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.2 | 0.5 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.2 | 0.5 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.2 | 0.5 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.2 | 0.5 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.2 | 0.7 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.2 | 0.2 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 0.5 | GO:0044252 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.2 | 0.2 | GO:1904851 | regulation of establishment of protein localization to telomere(GO:0070203) positive regulation of establishment of protein localization to telomere(GO:1904851) |
0.2 | 0.7 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.2 | 0.5 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.2 | 0.9 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 0.7 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.2 | 0.2 | GO:0032908 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
0.2 | 3.2 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.2 | 0.5 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.2 | 0.5 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.2 | 0.2 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.2 | 0.7 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.2 | 1.1 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.2 | 0.2 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.2 | 2.1 | GO:0051168 | nuclear export(GO:0051168) |
0.2 | 1.1 | GO:0033628 | regulation of cell adhesion mediated by integrin(GO:0033628) |
0.2 | 0.2 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.2 | 0.9 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 0.2 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 1.4 | GO:0051026 | chiasma assembly(GO:0051026) |
0.2 | 0.9 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.2 | 0.4 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.2 | 1.1 | GO:0007343 | egg activation(GO:0007343) |
0.2 | 3.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 0.2 | GO:1900044 | regulation of protein K63-linked ubiquitination(GO:1900044) |
0.2 | 0.4 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
0.2 | 0.2 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.2 | 2.7 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.2 | 9.1 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 0.4 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 1.1 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.2 | 0.2 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.2 | 0.9 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.2 | 0.2 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.2 | 0.7 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.2 | 1.3 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.2 | 1.3 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.2 | 1.1 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.2 | 1.3 | GO:0006560 | proline metabolic process(GO:0006560) |
0.2 | 1.7 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.2 | 0.9 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.2 | 0.2 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.2 | 1.3 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 0.2 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.2 | 0.9 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.2 | 0.6 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.2 | 0.2 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.2 | 0.2 | GO:0048478 | replication fork protection(GO:0048478) |
0.2 | 0.6 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.2 | 0.9 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.2 | 0.9 | GO:0009299 | mRNA transcription(GO:0009299) |
0.2 | 0.2 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.2 | 0.8 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 0.8 | GO:0030578 | PML body organization(GO:0030578) |
0.2 | 0.2 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.2 | 0.2 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.2 | 0.4 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.2 | 0.2 | GO:0009750 | response to fructose(GO:0009750) |
0.2 | 0.4 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.2 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.2 | 2.5 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.2 | 1.7 | GO:0048535 | lymph node development(GO:0048535) |
0.2 | 1.9 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.2 | 0.8 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.2 | 0.2 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.2 | 0.8 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.2 | 0.6 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.2 | 0.2 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 0.8 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 | 4.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.2 | 7.3 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.2 | 0.6 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 1.2 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.2 | 0.6 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 1.4 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.2 | 0.2 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.2 | 0.6 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) positive regulation of protein lipidation(GO:1903061) |
0.2 | 0.6 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.2 | 0.4 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.2 | 0.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.2 | 0.2 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.2 | 0.4 | GO:0060242 | contact inhibition(GO:0060242) |
0.2 | 1.6 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.2 | 0.6 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.2 | 0.8 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 0.2 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.2 | 1.4 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.2 | 0.8 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.2 | 1.4 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.2 | 0.2 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.2 | 1.4 | GO:0015893 | drug transport(GO:0015893) |
0.2 | 0.2 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.2 | 0.2 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.2 | 1.0 | GO:0046006 | regulation of activated T cell proliferation(GO:0046006) |
0.2 | 0.6 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.2 | 0.2 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.2 | 1.0 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.2 | 0.2 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.2 | 0.6 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.2 | 0.4 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.2 | 0.6 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.2 | 0.2 | GO:0048254 | snoRNA localization(GO:0048254) |
0.2 | 2.1 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.2 | 0.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.2 | 0.9 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 0.9 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.2 | 0.2 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.2 | 0.2 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.2 | 1.7 | GO:0007143 | female meiotic division(GO:0007143) |
0.2 | 0.9 | GO:0046831 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
0.2 | 0.9 | GO:0007135 | meiosis II(GO:0007135) |
0.2 | 0.2 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.2 | 0.6 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.2 | 0.6 | GO:1990874 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
0.2 | 0.5 | GO:0090114 | cargo loading into COPII-coated vesicle(GO:0090110) COPII-coated vesicle budding(GO:0090114) |
0.2 | 0.5 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.2 | 1.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.2 | 0.2 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.2 | 0.7 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.2 | 0.5 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 2.3 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 1.6 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.2 | 1.4 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 1.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 0.7 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 0.9 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 0.4 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.2 | 1.1 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.2 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 0.2 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.2 | 3.3 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.2 | 0.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.2 | 0.5 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.2 | 4.2 | GO:0006284 | base-excision repair(GO:0006284) |
0.2 | 1.2 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.2 | 3.1 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.2 | 0.5 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 0.3 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.2 | 0.5 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 0.7 | GO:0046697 | decidualization(GO:0046697) |
0.2 | 3.8 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 0.9 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 0.5 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.2 | 0.5 | GO:0043486 | histone exchange(GO:0043486) |
0.2 | 0.5 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 0.3 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 0.3 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.2 | 5.7 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.2 | 0.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 0.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 0.8 | GO:0050832 | defense response to fungus(GO:0050832) |
0.2 | 0.3 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.2 | 0.2 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.2 | 0.3 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.2 | 0.2 | GO:1902914 | regulation of protein polyubiquitination(GO:1902914) |
0.2 | 0.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.2 | 0.2 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.2 | 0.6 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 0.5 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.2 | 0.6 | GO:0032827 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.2 | 1.0 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.2 | 0.2 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.2 | 0.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 0.3 | GO:0002585 | positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) |
0.2 | 1.6 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.2 | 0.3 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.2 | 0.6 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 0.8 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.2 | 2.1 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.2 | 1.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.2 | 0.5 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.2 | 0.8 | GO:0060897 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.2 | 0.2 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.2 | 3.9 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.2 | 0.5 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.2 | 0.6 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.2 | 0.2 | GO:0060416 | response to growth hormone(GO:0060416) |
0.2 | 2.8 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.2 | 2.0 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.2 | 0.2 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 0.2 | GO:0070741 | response to interleukin-6(GO:0070741) |
0.2 | 0.3 | GO:0009595 | detection of biotic stimulus(GO:0009595) |
0.2 | 0.5 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.2 | 0.6 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.2 | 2.0 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.2 | 0.8 | GO:0006907 | pinocytosis(GO:0006907) |
0.2 | 0.3 | GO:0052472 | modulation by host of viral transcription(GO:0043921) positive regulation by host of viral transcription(GO:0043923) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.2 | 0.6 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 0.9 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 0.2 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.1 | 0.3 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 0.3 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.1 | 0.7 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 1.9 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.3 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.1 | 0.6 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.9 | GO:0036474 | cell death in response to hydrogen peroxide(GO:0036474) |
0.1 | 2.9 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 0.9 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 1.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.7 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 1.6 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.3 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 1.9 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.1 | 1.5 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.1 | 0.9 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 0.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.1 | 1.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.3 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.1 | 0.4 | GO:1990748 | cellular detoxification(GO:1990748) |
0.1 | 1.3 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.1 | 0.1 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.1 | 0.3 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.8 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.4 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.1 | 0.8 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.1 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 0.1 | GO:0032647 | regulation of interferon-alpha production(GO:0032647) |
0.1 | 0.8 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.1 | 0.4 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.4 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 1.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.3 | GO:0060068 | vagina development(GO:0060068) |
0.1 | 0.7 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.1 | 0.3 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.1 | 0.4 | GO:0061526 | acetylcholine secretion(GO:0061526) |
0.1 | 0.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 4.0 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.1 | 0.3 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.3 | GO:0032873 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.1 | 0.1 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) |
0.1 | 0.3 | GO:2001138 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.1 | 0.8 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.3 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.4 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.5 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.3 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 1.7 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.1 | 0.3 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.1 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
0.1 | 0.6 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 1.7 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.1 | GO:0060896 | neural plate pattern specification(GO:0060896) |
0.1 | 0.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.6 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 0.1 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.1 | 0.4 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.1 | 0.5 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.1 | 0.1 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.1 | 0.4 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 1.1 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.1 | 0.4 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 0.4 | GO:0031506 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.1 | 0.1 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.1 | 1.1 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 3.7 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 1.2 | GO:0072376 | protein activation cascade(GO:0072376) |
0.1 | 1.5 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.2 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 1.4 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 2.0 | GO:1902850 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.1 | 0.2 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.1 | 1.0 | GO:0072678 | T cell migration(GO:0072678) |
0.1 | 5.6 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 0.9 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.8 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.1 | 0.1 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.1 | 0.5 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.5 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.1 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.1 | 0.6 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
0.1 | 3.1 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.1 | 0.5 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 5.5 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.1 | 2.8 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 1.0 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.1 | 0.2 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.1 | 0.2 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.2 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.1 | 0.5 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 1.6 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.1 | 0.9 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.2 | GO:0030576 | Cajal body organization(GO:0030576) |
0.1 | 0.2 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 1.0 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.1 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.1 | 0.4 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.7 | GO:0060039 | pericardium development(GO:0060039) |
0.1 | 0.3 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.5 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 0.3 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.4 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.1 | 0.6 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.1 | 0.8 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.1 | 0.1 | GO:0007619 | courtship behavior(GO:0007619) female courtship behavior(GO:0008050) |
0.1 | 1.4 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.1 | 1.1 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.3 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.2 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.9 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.1 | 0.6 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.3 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.2 | GO:1902302 | potassium ion export across plasma membrane(GO:0097623) regulation of potassium ion export(GO:1902302) |
0.1 | 0.1 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.4 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
0.1 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.2 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.3 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 0.3 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.1 | 0.1 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.1 | 0.2 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 1.1 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.4 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.3 | GO:0045072 | regulation of interferon-gamma biosynthetic process(GO:0045072) |
0.1 | 0.3 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.5 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.1 | GO:2000323 | regulation of type B pancreatic cell development(GO:2000074) negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.1 | 0.8 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.1 | 1.0 | GO:0002687 | positive regulation of leukocyte migration(GO:0002687) |
0.1 | 0.8 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.7 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.7 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.4 | GO:0035590 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 0.7 | GO:0030316 | osteoclast differentiation(GO:0030316) |
0.1 | 0.1 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 0.3 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 0.2 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.1 | 0.3 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.1 | 0.4 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.1 | GO:0061009 | common bile duct development(GO:0061009) |
0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 1.2 | GO:0046466 | membrane lipid catabolic process(GO:0046466) |
0.1 | 0.1 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.1 | 0.4 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.1 | 0.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.2 | GO:0030852 | regulation of granulocyte differentiation(GO:0030852) |
0.1 | 0.9 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.1 | 0.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.2 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.1 | 0.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.1 | 0.1 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.1 | 0.4 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.1 | 0.3 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.1 | 0.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.1 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.1 | 0.5 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.1 | 0.7 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.1 | 0.2 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.4 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.2 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.5 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 0.1 | GO:0003266 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 | 2.6 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 1.0 | GO:0046916 | cellular transition metal ion homeostasis(GO:0046916) |
0.1 | 0.1 | GO:1901031 | regulation of response to reactive oxygen species(GO:1901031) |
0.1 | 0.2 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.3 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.1 | 0.1 | GO:0072422 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.1 | 0.4 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 0.2 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.1 | 0.2 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.1 | 0.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 2.7 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.1 | 0.2 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.1 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.1 | 0.9 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.1 | 0.2 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.4 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.2 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 1.9 | GO:0007492 | endoderm development(GO:0007492) |
0.1 | 0.1 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.1 | 0.4 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.1 | 0.3 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.1 | GO:0034310 | ethanol metabolic process(GO:0006067) ethanol catabolic process(GO:0006068) ethanol oxidation(GO:0006069) primary alcohol catabolic process(GO:0034310) |
0.1 | 0.5 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 0.1 | GO:0044786 | cell cycle DNA replication(GO:0044786) |
0.1 | 0.1 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.1 | 0.4 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.3 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 0.2 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.1 | 0.4 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 1.4 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
0.1 | 0.5 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.1 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.1 | 0.4 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.1 | 1.1 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.1 | 0.2 | GO:0007418 | ventral midline development(GO:0007418) |
0.1 | 0.8 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.1 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.3 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 0.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 2.5 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.2 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.1 | 0.5 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 2.4 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.1 | 0.1 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.1 | 0.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.1 | GO:0046112 | nucleobase biosynthetic process(GO:0046112) |
0.1 | 0.3 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.2 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
0.1 | 0.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 1.3 | GO:0048144 | fibroblast proliferation(GO:0048144) |
0.1 | 0.4 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.1 | 0.5 | GO:0072676 | lymphocyte migration(GO:0072676) |
0.1 | 0.1 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.1 | GO:0033574 | response to testosterone(GO:0033574) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 1.4 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.1 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.1 | 0.2 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.1 | 0.1 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.1 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.1 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.3 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.2 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.3 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.1 | 0.1 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 0.8 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.1 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.1 | 0.9 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.2 | GO:0006971 | hypotonic response(GO:0006971) |
0.1 | 0.1 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.1 | 0.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.1 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.1 | 0.1 | GO:0006862 | nucleotide transport(GO:0006862) |
0.1 | 0.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.1 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.0 | 0.0 | GO:0051985 | negative regulation of chromosome segregation(GO:0051985) |
0.0 | 0.0 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.1 | GO:0010043 | response to zinc ion(GO:0010043) |
0.0 | 0.0 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
0.0 | 0.1 | GO:0003283 | atrial septum development(GO:0003283) |
0.0 | 0.8 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.0 | 0.0 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.0 | 0.4 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.2 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.1 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.0 | 0.7 | GO:0006959 | humoral immune response(GO:0006959) |
0.0 | 0.9 | GO:0046849 | bone remodeling(GO:0046849) |
0.0 | 0.2 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.1 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
0.0 | 0.0 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 4.5 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.0 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.0 | 0.5 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.0 | 0.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.7 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 0.0 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.0 | 0.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.0 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.0 | 0.1 | GO:0019080 | viral gene expression(GO:0019080) |
0.0 | 0.0 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.0 | 0.0 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.3 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 2.5 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 0.1 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.7 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.0 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.0 | 0.0 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) pilomotor reflex(GO:0097195) |
0.0 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.0 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.0 | 0.1 | GO:0042737 | drug catabolic process(GO:0042737) |
0.0 | 0.0 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.2 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 0.2 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.0 | 0.2 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.0 | 0.0 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.0 | GO:0032196 | transposition(GO:0032196) |
0.0 | 0.0 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.0 | 0.3 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.0 | 0.1 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) |
0.0 | 0.0 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.2 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.0 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.0 | 0.0 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.0 | 0.0 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.0 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.0 | GO:0044819 | mitotic G1/S transition checkpoint(GO:0044819) |
0.0 | 0.1 | GO:0042107 | cytokine metabolic process(GO:0042107) |
0.0 | 0.0 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.0 | 0.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.1 | GO:0044704 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.0 | 0.1 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.0 | GO:0003071 | renal system process involved in regulation of systemic arterial blood pressure(GO:0003071) |
0.0 | 0.0 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.0 | 0.0 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.0 | 0.1 | GO:0050892 | intestinal absorption(GO:0050892) |
0.0 | 0.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.0 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.0 | 0.0 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.0 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.0 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.0 | 1.2 | GO:0016072 | rRNA metabolic process(GO:0016072) |
0.0 | 0.0 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.0 | 0.1 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.0 | 0.1 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.0 | 1.8 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0060457 | negative regulation of digestive system process(GO:0060457) |
0.0 | 0.2 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.0 | GO:0070417 | cellular response to cold(GO:0070417) |
0.0 | 0.0 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.1 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.0 | 0.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.1 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.0 | 0.0 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.1 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.0 | 0.0 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.0 | 0.0 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.0 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.0 | 0.0 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.6 | 19.9 | GO:0097451 | glial limiting end-foot(GO:0097451) |
4.7 | 23.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
3.8 | 22.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
2.5 | 7.5 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
2.4 | 7.3 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
2.3 | 11.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
2.0 | 10.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.8 | 5.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.7 | 17.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.7 | 10.4 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
1.4 | 4.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
1.4 | 6.9 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.4 | 2.7 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
1.3 | 1.3 | GO:0097450 | astrocyte end-foot(GO:0097450) |
1.2 | 4.7 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.1 | 3.2 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.1 | 3.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.1 | 4.2 | GO:0005642 | annulate lamellae(GO:0005642) |
1.0 | 4.1 | GO:0031298 | replication fork protection complex(GO:0031298) |
1.0 | 5.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.0 | 3.0 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
1.0 | 3.0 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
1.0 | 9.6 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.9 | 2.8 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.9 | 7.3 | GO:0001650 | fibrillar center(GO:0001650) |
0.9 | 3.5 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.9 | 3.5 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.9 | 2.6 | GO:0031523 | Myb complex(GO:0031523) |
0.9 | 1.7 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.8 | 2.5 | GO:0071564 | npBAF complex(GO:0071564) |
0.8 | 4.0 | GO:0031983 | vesicle lumen(GO:0031983) |
0.8 | 2.4 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.8 | 4.7 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.8 | 6.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.8 | 3.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.8 | 6.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.8 | 4.5 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.7 | 0.7 | GO:0005712 | chiasma(GO:0005712) |
0.7 | 5.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.7 | 5.0 | GO:0042627 | chylomicron(GO:0042627) |
0.7 | 9.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.7 | 2.8 | GO:1990130 | Iml1 complex(GO:1990130) |
0.7 | 2.8 | GO:0035339 | SPOTS complex(GO:0035339) |
0.7 | 3.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.7 | 61.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.7 | 2.0 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.7 | 0.7 | GO:0032010 | phagolysosome(GO:0032010) |
0.6 | 1.9 | GO:0070552 | BRISC complex(GO:0070552) |
0.6 | 2.5 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.6 | 2.5 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.6 | 1.9 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.6 | 1.9 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.6 | 1.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.6 | 1.8 | GO:0097413 | Lewy body(GO:0097413) |
0.6 | 4.9 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.6 | 18.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.6 | 4.9 | GO:0042581 | specific granule(GO:0042581) |
0.6 | 4.8 | GO:0030056 | hemidesmosome(GO:0030056) |
0.6 | 1.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.6 | 13.6 | GO:0034451 | centriolar satellite(GO:0034451) |
0.6 | 2.9 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.6 | 1.8 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.6 | 0.6 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.6 | 1.7 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.6 | 4.6 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.6 | 3.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.6 | 3.5 | GO:0097342 | ripoptosome(GO:0097342) |
0.6 | 0.6 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.5 | 17.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.5 | 2.7 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.5 | 2.1 | GO:0072487 | MSL complex(GO:0072487) |
0.5 | 2.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.5 | 1.1 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.5 | 5.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.5 | 11.5 | GO:0008305 | integrin complex(GO:0008305) |
0.5 | 1.6 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.5 | 1.0 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.5 | 2.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.5 | 37.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.5 | 1.5 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.5 | 7.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.5 | 2.5 | GO:0005638 | lamin filament(GO:0005638) |
0.5 | 4.0 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.5 | 6.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.5 | 1.5 | GO:0000805 | X chromosome(GO:0000805) |
0.5 | 2.9 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.5 | 2.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.5 | 2.9 | GO:0042629 | mast cell granule(GO:0042629) |
0.5 | 0.9 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.5 | 1.4 | GO:0035061 | interchromatin granule(GO:0035061) |
0.5 | 2.3 | GO:0097422 | tubular endosome(GO:0097422) |
0.5 | 3.2 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.5 | 2.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.4 | 6.7 | GO:0000145 | exocyst(GO:0000145) |
0.4 | 2.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.4 | 4.9 | GO:0042555 | MCM complex(GO:0042555) |
0.4 | 1.7 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.4 | 1.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.4 | 9.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.4 | 1.3 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.4 | 3.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.4 | 2.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.4 | 2.9 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.4 | 2.9 | GO:0002102 | podosome(GO:0002102) |
0.4 | 0.8 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.4 | 1.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.4 | 0.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.4 | 0.8 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.4 | 1.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.4 | 17.0 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.4 | 3.8 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.4 | 0.7 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.4 | 1.5 | GO:0097452 | GAIT complex(GO:0097452) |
0.4 | 1.5 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.4 | 4.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.4 | 10.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.4 | 1.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.4 | 0.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.4 | 2.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.4 | 0.7 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.4 | 3.2 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.4 | 5.7 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.4 | 1.8 | GO:0016589 | NURF complex(GO:0016589) |
0.4 | 2.1 | GO:0031415 | NatA complex(GO:0031415) |
0.4 | 0.4 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.4 | 1.4 | GO:0005687 | U4 snRNP(GO:0005687) |
0.4 | 28.9 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.4 | 1.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.4 | 1.1 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 5.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.3 | 0.3 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.3 | 1.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.3 | 0.7 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.3 | 1.0 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.3 | 35.2 | GO:0000793 | condensed chromosome(GO:0000793) |
0.3 | 1.7 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.3 | 1.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.3 | 0.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.3 | 2.9 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 0.3 | GO:0089701 | U2AF(GO:0089701) |
0.3 | 1.0 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.3 | 9.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.3 | 1.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.3 | 26.1 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.3 | 3.7 | GO:0045120 | pronucleus(GO:0045120) |
0.3 | 2.5 | GO:0045179 | apical cortex(GO:0045179) |
0.3 | 20.0 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.3 | 0.9 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 1.2 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.3 | 0.3 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.3 | 0.3 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.3 | 7.0 | GO:0097228 | sperm principal piece(GO:0097228) |
0.3 | 1.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 6.2 | GO:0071010 | prespliceosome(GO:0071010) |
0.3 | 0.6 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.3 | 0.3 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.3 | 1.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.3 | 2.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 0.9 | GO:1990923 | PET complex(GO:1990923) |
0.3 | 1.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.3 | 2.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.3 | 5.1 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.3 | 0.6 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.3 | 3.1 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 1.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.3 | 0.6 | GO:1990462 | omegasome(GO:1990462) |
0.3 | 1.1 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.3 | 7.1 | GO:0015030 | Cajal body(GO:0015030) |
0.3 | 1.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.3 | 1.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.3 | 1.6 | GO:0090543 | Flemming body(GO:0090543) |
0.3 | 0.3 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.3 | 2.9 | GO:0032426 | stereocilium tip(GO:0032426) |
0.3 | 1.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.3 | 3.7 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.3 | 10.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.3 | 2.1 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.3 | 0.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.3 | 3.0 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.3 | 6.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 1.5 | GO:0071986 | Ragulator complex(GO:0071986) |
0.3 | 1.5 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.2 | 1.0 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 0.7 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 2.0 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 8.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 1.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 2.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 0.5 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.2 | 0.5 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.2 | 3.6 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.2 | 0.7 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.2 | 2.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 1.4 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 8.6 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 1.8 | GO:0099738 | cell cortex region(GO:0099738) |
0.2 | 0.7 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 0.9 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.2 | 8.0 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 0.7 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.2 | 1.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 0.4 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.2 | 0.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 1.3 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 0.9 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.2 | 1.1 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 2.6 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 2.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 2.8 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 45.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 1.7 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 26.6 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.2 | 0.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 0.6 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 0.4 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 0.8 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 0.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.2 | 0.6 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 1.0 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 2.4 | GO:0001741 | XY body(GO:0001741) |
0.2 | 8.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 0.4 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 11.0 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.2 | 11.4 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 1.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 2.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 0.9 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 3.7 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 5.4 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 1.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 0.6 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 0.9 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 0.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 0.7 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.2 | 1.6 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 15.4 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.2 | 1.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 0.9 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 2.4 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 0.3 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.2 | 2.0 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 1.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 1.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 0.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 0.5 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 0.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 0.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 15.1 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.2 | 0.6 | GO:0001739 | sex chromatin(GO:0001739) |
0.2 | 0.8 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 1.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 0.2 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 2.0 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 2.6 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.2 | 0.9 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 4.2 | GO:0098687 | chromosomal region(GO:0098687) |
0.1 | 2.3 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 43.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 0.7 | GO:0034719 | SMN complex(GO:0032797) SMN-Sm protein complex(GO:0034719) |
0.1 | 0.1 | GO:0031261 | GINS complex(GO:0000811) DNA replication preinitiation complex(GO:0031261) |
0.1 | 2.9 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 13.9 | GO:0016604 | nuclear body(GO:0016604) |
0.1 | 0.4 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 3.7 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 2.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 1.6 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 2.0 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.7 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.7 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.1 | 0.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.9 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 2.5 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.4 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.1 | 13.6 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 14.5 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 0.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 16.4 | GO:0005635 | nuclear envelope(GO:0005635) |
0.1 | 0.5 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 0.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 1.3 | GO:0036126 | sperm flagellum(GO:0036126) |
0.1 | 0.8 | GO:0070187 | telosome(GO:0070187) |
0.1 | 1.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.7 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 1.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 3.5 | GO:0030118 | clathrin coat(GO:0030118) |
0.1 | 32.5 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 12.8 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 1.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 1.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 4.2 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 103.5 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.4 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.1 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 0.1 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 3.9 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.4 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 0.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.3 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.1 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.1 | 0.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.3 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.1 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.2 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 0.5 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.1 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 0.2 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 4.1 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 2.6 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.1 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 0.1 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 0.8 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 11.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 3.2 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 0.0 | GO:0001652 | granular component(GO:0001652) |
0.0 | 66.8 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.3 | GO:0038201 | TOR complex(GO:0038201) |
0.0 | 0.4 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.2 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.0 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.0 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.1 | GO:0033010 | paranodal junction(GO:0033010) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.9 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 2.0 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.0 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.7 | 22.7 | GO:0031720 | haptoglobin binding(GO:0031720) |
3.4 | 13.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
2.7 | 13.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
2.5 | 7.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
2.5 | 7.5 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
2.2 | 15.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.9 | 5.6 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
1.8 | 5.5 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.7 | 3.4 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
1.7 | 5.0 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
1.7 | 6.7 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.7 | 5.0 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
1.6 | 4.9 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.6 | 3.3 | GO:0034618 | arginine binding(GO:0034618) |
1.6 | 8.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
1.6 | 11.0 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
1.5 | 4.6 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.5 | 13.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.5 | 1.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
1.5 | 6.1 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.5 | 4.4 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
1.5 | 11.7 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
1.5 | 5.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
1.5 | 4.4 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
1.4 | 4.3 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
1.4 | 8.6 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
1.4 | 4.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.3 | 8.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.3 | 4.0 | GO:0009041 | uridylate kinase activity(GO:0009041) |
1.3 | 1.3 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
1.3 | 5.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.3 | 12.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.3 | 7.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
1.3 | 3.8 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.2 | 8.7 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
1.2 | 6.0 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
1.2 | 3.6 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
1.2 | 3.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.2 | 2.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.2 | 3.5 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
1.2 | 3.5 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
1.1 | 3.4 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.1 | 4.5 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
1.1 | 10.0 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
1.1 | 4.4 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
1.1 | 8.6 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.1 | 4.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
1.0 | 3.1 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
1.0 | 8.3 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
1.0 | 3.1 | GO:0019862 | IgA binding(GO:0019862) |
1.0 | 2.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
1.0 | 5.1 | GO:0005499 | vitamin D binding(GO:0005499) |
1.0 | 4.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
1.0 | 4.0 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.0 | 5.0 | GO:0035473 | lipase binding(GO:0035473) |
1.0 | 3.0 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
1.0 | 3.9 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
1.0 | 2.9 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.0 | 2.9 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
1.0 | 2.9 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
1.0 | 2.9 | GO:1990188 | euchromatin binding(GO:1990188) |
0.9 | 6.6 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.9 | 3.8 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.9 | 2.7 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.9 | 6.4 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.9 | 2.7 | GO:0008430 | selenium binding(GO:0008430) |
0.9 | 7.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.9 | 2.7 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.9 | 13.4 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.9 | 2.7 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.9 | 7.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.9 | 6.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.9 | 2.6 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.9 | 2.6 | GO:0004064 | arylesterase activity(GO:0004064) |
0.9 | 10.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.9 | 1.7 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.9 | 6.0 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.8 | 3.4 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.8 | 2.5 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.8 | 3.3 | GO:0032564 | dATP binding(GO:0032564) |
0.8 | 0.8 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.8 | 4.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.8 | 2.4 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.8 | 2.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.8 | 3.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.8 | 3.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.8 | 1.6 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.8 | 4.7 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.8 | 3.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.8 | 2.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.8 | 0.8 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.8 | 7.0 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.8 | 27.1 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.8 | 4.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.8 | 3.8 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.8 | 1.5 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.8 | 3.0 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.8 | 4.5 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.8 | 2.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.7 | 2.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.7 | 2.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.7 | 2.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.7 | 2.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.7 | 15.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.7 | 0.7 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.7 | 2.9 | GO:0005534 | galactose binding(GO:0005534) |
0.7 | 2.9 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.7 | 2.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.7 | 2.8 | GO:0038132 | neuregulin binding(GO:0038132) |
0.7 | 3.5 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.7 | 1.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.7 | 1.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.7 | 4.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.7 | 2.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.7 | 3.5 | GO:0016936 | galactoside binding(GO:0016936) |
0.7 | 2.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.7 | 4.9 | GO:0005113 | patched binding(GO:0005113) |
0.7 | 5.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.7 | 1.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.7 | 8.8 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.7 | 2.0 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.7 | 2.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.7 | 3.4 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.7 | 2.7 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.7 | 2.0 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.7 | 8.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.7 | 2.6 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.7 | 0.7 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.7 | 5.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.6 | 2.6 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.6 | 3.8 | GO:0043559 | insulin binding(GO:0043559) |
0.6 | 1.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.6 | 1.9 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.6 | 1.3 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.6 | 3.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.6 | 11.9 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.6 | 0.6 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.6 | 3.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.6 | 3.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.6 | 8.0 | GO:0010181 | FMN binding(GO:0010181) |
0.6 | 3.7 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.6 | 1.8 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.6 | 3.0 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.6 | 1.8 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.6 | 3.6 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.6 | 3.0 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.6 | 1.8 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.6 | 1.2 | GO:0035877 | death effector domain binding(GO:0035877) |
0.6 | 5.9 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.6 | 4.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.6 | 5.8 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.6 | 1.7 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.6 | 3.5 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.6 | 14.4 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.6 | 3.5 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.6 | 0.6 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.6 | 2.9 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.6 | 1.7 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.6 | 1.7 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.6 | 1.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.6 | 3.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.6 | 2.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.6 | 3.4 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.6 | 1.7 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.6 | 9.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.6 | 4.4 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.6 | 4.4 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.5 | 1.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.5 | 1.6 | GO:0019961 | interferon binding(GO:0019961) |
0.5 | 2.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.5 | 4.3 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.5 | 4.8 | GO:0001846 | opsonin binding(GO:0001846) |
0.5 | 9.6 | GO:0030371 | translation repressor activity(GO:0030371) |
0.5 | 1.6 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.5 | 2.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.5 | 1.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.5 | 5.7 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.5 | 1.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.5 | 10.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.5 | 1.0 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.5 | 2.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.5 | 2.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.5 | 0.5 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.5 | 1.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.5 | 1.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.5 | 4.6 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.5 | 10.1 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.5 | 3.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.5 | 7.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.5 | 3.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.5 | 14.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.5 | 1.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.5 | 0.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.5 | 2.0 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.5 | 2.5 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.5 | 2.0 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.5 | 0.5 | GO:0015250 | water channel activity(GO:0015250) |
0.5 | 3.9 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.5 | 1.4 | GO:0030984 | kininogen binding(GO:0030984) |
0.5 | 4.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.5 | 3.8 | GO:0034582 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.5 | 4.7 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.5 | 0.5 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.5 | 1.4 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.5 | 1.4 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.5 | 6.9 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.5 | 5.0 | GO:0044466 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.5 | 3.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.5 | 2.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 0.4 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.4 | 1.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 8.5 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.4 | 1.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.4 | 1.8 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.4 | 1.3 | GO:0070061 | fructose binding(GO:0070061) |
0.4 | 0.4 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.4 | 3.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.4 | 1.3 | GO:0042887 | peptide-transporting ATPase activity(GO:0015440) amide transmembrane transporter activity(GO:0042887) peptide transmembrane transporter activity(GO:1904680) |
0.4 | 1.8 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.4 | 1.3 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.4 | 3.1 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.4 | 8.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.4 | 1.7 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.4 | 1.7 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.4 | 4.3 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.4 | 1.3 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.4 | 0.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.4 | 1.3 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 2.6 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.4 | 3.0 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.4 | 1.7 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.4 | 5.1 | GO:0005542 | folic acid binding(GO:0005542) |
0.4 | 3.4 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.4 | 1.3 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.4 | 2.5 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.4 | 3.0 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.4 | 2.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.4 | 0.8 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.4 | 12.1 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.4 | 0.8 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.4 | 3.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.4 | 0.8 | GO:0004103 | choline kinase activity(GO:0004103) |
0.4 | 2.5 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.4 | 0.4 | GO:0045340 | mercury ion binding(GO:0045340) |
0.4 | 1.6 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.4 | 2.5 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.4 | 8.6 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.4 | 1.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.4 | 2.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.4 | 0.4 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.4 | 2.0 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.4 | 1.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.4 | 12.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.4 | 3.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.4 | 2.0 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.4 | 5.6 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.4 | 2.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.4 | 0.4 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.4 | 1.2 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.4 | 3.1 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.4 | 3.5 | GO:0001848 | complement binding(GO:0001848) |
0.4 | 2.7 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.4 | 0.4 | GO:0015923 | mannosidase activity(GO:0015923) |
0.4 | 1.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.4 | 5.0 | GO:0008143 | poly(A) binding(GO:0008143) |
0.4 | 1.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.4 | 1.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.4 | 1.9 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.4 | 1.1 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.4 | 1.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.4 | 4.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.4 | 1.9 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.4 | 1.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 2.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.4 | 4.4 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.4 | 1.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.4 | 0.7 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.4 | 1.8 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.4 | 2.2 | GO:0016208 | AMP binding(GO:0016208) |
0.4 | 1.4 | GO:0034452 | dynactin binding(GO:0034452) |
0.4 | 17.5 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.4 | 2.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.4 | 0.7 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.4 | 0.7 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.4 | 4.6 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.4 | 2.8 | GO:0005123 | death receptor binding(GO:0005123) |
0.3 | 7.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.3 | 1.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 2.8 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.3 | 1.7 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.3 | 5.1 | GO:0043531 | ADP binding(GO:0043531) |
0.3 | 1.4 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.3 | 0.3 | GO:0019825 | oxygen binding(GO:0019825) |
0.3 | 1.7 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 4.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.3 | 3.6 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.3 | 1.0 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.3 | 0.7 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.3 | 1.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.3 | 1.3 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.3 | 0.6 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.3 | 1.0 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.3 | 1.9 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.3 | 3.8 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.3 | 1.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.3 | 1.3 | GO:0008199 | ferric iron binding(GO:0008199) |
0.3 | 1.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 2.9 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.3 | 1.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.3 | 1.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.3 | 1.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.3 | 1.6 | GO:0016209 | antioxidant activity(GO:0016209) |
0.3 | 1.3 | GO:0035197 | siRNA binding(GO:0035197) |
0.3 | 7.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.3 | 1.9 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.3 | 2.5 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.3 | 2.8 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.3 | 4.3 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.3 | 2.5 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.3 | 0.9 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.3 | 1.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.3 | 0.9 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 1.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 2.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 0.3 | GO:0032190 | acrosin binding(GO:0032190) |
0.3 | 0.6 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.3 | 0.9 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.3 | 10.7 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.3 | 3.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.3 | 4.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 1.8 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.3 | 0.3 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.3 | 0.9 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 1.2 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.3 | 1.4 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.3 | 1.7 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.3 | 2.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 0.3 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.3 | 1.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.3 | 2.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.3 | 1.7 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.3 | 2.2 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.3 | 2.5 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 0.3 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.3 | 1.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.3 | 0.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.3 | 1.7 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.3 | 1.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.3 | 1.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.3 | 9.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 0.3 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.3 | 1.6 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.3 | 3.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.3 | 1.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 0.3 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.3 | 5.1 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.3 | 1.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.3 | 0.5 | GO:0000339 | RNA cap binding(GO:0000339) |
0.3 | 1.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.3 | 2.4 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.3 | 29.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.3 | 0.8 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 0.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.3 | 1.0 | GO:0038100 | nodal binding(GO:0038100) |
0.3 | 0.8 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.3 | 0.8 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.3 | 1.0 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.3 | 1.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.3 | 0.8 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.3 | 1.3 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 3.7 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.2 | 1.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.7 | GO:0019002 | GMP binding(GO:0019002) |
0.2 | 4.2 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 0.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 0.7 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.2 | 0.7 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 3.9 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.2 | 1.0 | GO:0019808 | polyamine binding(GO:0019808) |
0.2 | 0.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 1.4 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.2 | 0.2 | GO:0019956 | chemokine binding(GO:0019956) |
0.2 | 4.8 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 0.7 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.2 | 2.4 | GO:0045182 | translation regulator activity(GO:0045182) |
0.2 | 1.4 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.2 | 0.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.2 | 0.7 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.2 | 1.4 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.2 | 2.8 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 0.7 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 1.6 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 1.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.2 | 0.9 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.2 | 1.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 0.4 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.2 | 7.3 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.2 | 2.9 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 29.2 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.2 | 0.4 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.2 | 2.2 | GO:0035173 | histone kinase activity(GO:0035173) |
0.2 | 0.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 1.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 2.4 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 1.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 1.9 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 0.6 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.2 | 2.8 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.2 | 1.3 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.2 | 0.4 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 2.1 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 5.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 1.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 2.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 0.4 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 1.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.2 | 3.7 | GO:0020037 | heme binding(GO:0020037) |
0.2 | 0.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.2 | 1.0 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.2 | 0.8 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.2 | 10.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 6.0 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.2 | 1.0 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.2 | 1.0 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 1.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 1.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 1.0 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.2 | 3.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 0.8 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 4.7 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.2 | 8.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 0.4 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.2 | 33.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 0.6 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 5.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.2 | 0.4 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.2 | 1.3 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.2 | 0.2 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.2 | 1.1 | GO:0070402 | NADPH binding(GO:0070402) |
0.2 | 1.5 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
0.2 | 1.7 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 0.4 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.2 | 4.5 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.2 | 0.9 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 0.2 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.2 | 3.6 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.2 | 2.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 0.9 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 1.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 0.7 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.2 | 2.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.2 | 0.9 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 1.7 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 0.7 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 1.0 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 0.2 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.2 | 0.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.2 | 0.5 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 6.7 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.2 | 0.5 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.2 | 0.3 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.2 | 0.5 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 4.4 | GO:0052767 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) 3,4-dihydrocoumarin hydrolase activity(GO:0018733) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) retinyl-palmitate esterase activity(GO:0050253) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.2 | 0.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 0.3 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.2 | 1.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 0.7 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.2 | 0.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 6.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 0.7 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 0.7 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 0.3 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 1.0 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 0.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 0.3 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.2 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 3.9 | GO:0000049 | tRNA binding(GO:0000049) |
0.2 | 0.5 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.2 | 1.0 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.2 | 0.6 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.2 | 0.5 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.2 | 2.2 | GO:0004495 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
0.2 | 4.5 | GO:0005507 | copper ion binding(GO:0005507) |
0.2 | 5.6 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.2 | 0.5 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.2 | 0.5 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 6.2 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 0.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 0.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.2 | 0.6 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 2.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 0.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 0.6 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.1 | 1.6 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.3 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 0.7 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 2.8 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.4 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.4 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 2.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 7.2 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.3 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.4 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.6 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.3 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 1.8 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 13.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.4 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.1 | 0.4 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 1.4 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 4.2 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 3.4 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 6.5 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.4 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 22.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 8.4 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 0.5 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 0.1 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.3 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.4 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 1.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 0.3 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.4 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 2.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.2 | GO:0015928 | fucosidase activity(GO:0015928) |
0.1 | 11.8 | GO:0005506 | iron ion binding(GO:0005506) |
0.1 | 0.6 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.5 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 6.1 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 0.2 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 2.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 1.0 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.1 | 2.5 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.7 | GO:0016160 | amylase activity(GO:0016160) |
0.1 | 0.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 2.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.1 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 1.0 | GO:0048029 | monosaccharide binding(GO:0048029) |
0.1 | 1.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.1 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 0.3 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.1 | 0.3 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 5.9 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.1 | 0.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 1.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.4 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 19.4 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.3 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 1.0 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.4 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.2 | GO:0004518 | nuclease activity(GO:0004518) |
0.1 | 0.8 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.1 | 0.8 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 1.9 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 3.3 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 2.3 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 4.4 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.5 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.1 | 6.1 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.9 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.4 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.4 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 2.9 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 0.2 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 0.6 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.5 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.1 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.1 | 0.3 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 4.2 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.4 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.3 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 0.2 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 1.5 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.3 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.2 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 0.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 1.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 1.9 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 3.2 | GO:0004519 | endonuclease activity(GO:0004519) |
0.1 | 0.4 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 0.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 2.9 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.1 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.6 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.1 | 0.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.3 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.1 | GO:0060229 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.1 | 0.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 5.0 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.1 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.1 | 0.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 1.9 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 1.2 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.1 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 0.9 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.1 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 0.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.4 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 0.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.4 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.0 | 0.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.7 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.0 | 2.7 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.0 | 0.6 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.0 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.0 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 1.9 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 0.5 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.0 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.0 | 0.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.0 | 1.7 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 1.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.0 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.2 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.3 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.0 | 1.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 3.6 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.7 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 1.1 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 1.0 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.1 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.1 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.2 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.0 | 0.3 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.2 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.0 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.1 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.0 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.0 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.3 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.0 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 6.7 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.0 | 0.1 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.0 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.2 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 3.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
1.2 | 54.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.1 | 7.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.0 | 35.5 | PID EPO PATHWAY | EPO signaling pathway |
1.0 | 12.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.9 | 9.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.9 | 2.8 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.9 | 1.8 | ST STAT3 PATHWAY | STAT3 Pathway |
0.9 | 6.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.9 | 0.9 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.9 | 0.9 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.9 | 25.6 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.8 | 6.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.7 | 18.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.7 | 0.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.7 | 12.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.6 | 0.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.6 | 3.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.6 | 15.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.6 | 8.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.6 | 6.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.6 | 38.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.6 | 7.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.5 | 3.6 | PID AURORA A PATHWAY | Aurora A signaling |
0.5 | 17.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.5 | 31.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.5 | 7.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.5 | 1.9 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.5 | 16.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.5 | 9.5 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.4 | 6.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.4 | 6.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.4 | 8.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.4 | 1.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.4 | 6.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.4 | 9.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.4 | 3.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.4 | 11.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.4 | 8.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.4 | 2.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.4 | 35.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.4 | 4.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.3 | 11.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.3 | 3.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 7.7 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 10.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.3 | 4.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 2.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.3 | 0.6 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.3 | 1.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.3 | 0.6 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 2.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.3 | 0.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.3 | 12.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 2.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 6.5 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.3 | 8.4 | PID E2F PATHWAY | E2F transcription factor network |
0.3 | 8.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.3 | 7.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.3 | 1.1 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 3.7 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.3 | 1.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.3 | 2.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.3 | 2.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 4.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 7.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 4.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 0.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 1.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 6.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 5.4 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 1.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 4.5 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 3.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 1.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 2.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 3.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 1.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 1.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.2 | 0.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 2.2 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.2 | 1.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 2.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 3.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 0.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 0.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 3.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 3.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 2.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 1.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 1.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 2.1 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 1.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 1.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 0.2 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 0.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.4 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 1.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.3 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 0.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 13.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 0.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.1 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.1 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 32.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.5 | 17.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.4 | 13.9 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.4 | 22.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.2 | 35.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
1.2 | 10.7 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
1.2 | 15.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
1.1 | 11.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.0 | 5.2 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
1.0 | 28.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
1.0 | 5.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.0 | 17.0 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
1.0 | 11.0 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.9 | 15.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.8 | 10.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.8 | 0.8 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.8 | 9.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.7 | 6.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.7 | 16.2 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.7 | 11.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.7 | 9.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.7 | 9.7 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.7 | 1.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.7 | 13.9 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.7 | 4.6 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.6 | 6.4 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.6 | 9.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.6 | 0.6 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.6 | 19.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.6 | 29.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.6 | 8.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.6 | 7.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.6 | 1.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.6 | 6.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.6 | 0.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.6 | 4.0 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.6 | 5.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.6 | 1.1 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.6 | 9.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.6 | 9.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.6 | 7.2 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.6 | 5.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.5 | 3.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.5 | 3.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.5 | 5.8 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.5 | 4.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.5 | 50.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.5 | 12.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.5 | 5.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.5 | 5.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.5 | 4.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.5 | 16.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.5 | 3.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.5 | 2.8 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.5 | 5.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.5 | 7.9 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.5 | 0.9 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.5 | 4.6 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.5 | 7.7 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.5 | 3.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.5 | 1.4 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.4 | 1.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.4 | 1.3 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.4 | 11.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.4 | 6.0 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.4 | 0.4 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.4 | 5.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.4 | 0.4 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.4 | 0.4 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.4 | 2.8 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.4 | 1.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.4 | 1.9 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.4 | 1.9 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.4 | 3.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.4 | 4.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.4 | 4.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.4 | 3.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.4 | 4.5 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.4 | 5.5 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.4 | 3.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.4 | 1.1 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.4 | 32.1 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.3 | 4.5 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.3 | 5.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.3 | 1.7 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.3 | 5.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.3 | 0.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.3 | 1.0 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.3 | 2.0 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 3.0 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.3 | 7.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 1.3 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.3 | 1.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 7.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.3 | 7.0 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.3 | 2.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.3 | 0.3 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.3 | 1.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.3 | 0.3 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.3 | 6.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.3 | 6.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 6.1 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.3 | 7.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 0.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.3 | 20.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.3 | 1.2 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.3 | 7.8 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.3 | 0.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 4.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.3 | 2.0 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.3 | 2.9 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 1.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.3 | 2.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 2.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.3 | 2.7 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.3 | 0.8 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.3 | 4.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.3 | 0.8 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.3 | 3.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 3.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.3 | 2.3 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.3 | 2.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 3.9 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 4.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 3.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 1.3 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.2 | 4.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 8.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 3.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 5.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 4.6 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.2 | 2.9 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.2 | 2.5 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.2 | 2.7 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 1.0 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.2 | 1.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 2.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 1.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 6.5 | REACTOME TRANSLATION | Genes involved in Translation |
0.2 | 1.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 1.7 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
0.2 | 1.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 4.6 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.2 | 0.7 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.2 | 2.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 4.2 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.2 | 2.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 0.5 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.2 | 19.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 3.0 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 2.8 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 0.7 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.2 | 2.9 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 10.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.2 | 0.8 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.2 | 2.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 3.4 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.2 | 1.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 4.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 18.1 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 11.8 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.9 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 1.7 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 2.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 2.3 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 3.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 1.0 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 3.0 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.8 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.1 | 1.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.4 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 0.7 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 2.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.0 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.1 | 0.4 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 3.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.9 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 0.5 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 7.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 1.7 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 2.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 1.7 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 1.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 0.1 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 0.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.8 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.9 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 0.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 0.3 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 0.2 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 0.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 3.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.1 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.2 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.0 | 0.1 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |